
Monday, March 24, 2025 8:29:46 AM

Recent OCEA News
- Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development • GlobeNewswire Inc. • 02/10/2025 01:00:00 PM
- Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway • GlobeNewswire Inc. • 01/29/2025 01:30:00 PM
- Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q • GlobeNewswire Inc. • 11/22/2024 09:45:00 PM
- Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter • GlobeNewswire Inc. • 10/22/2024 08:45:00 PM
- Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses • GlobeNewswire Inc. • 10/01/2024 12:01:00 PM
- Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms • GlobeNewswire Inc. • 08/27/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:30:33 PM
- Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q • GlobeNewswire Inc. • 08/23/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 09:26:10 PM
- Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 • GlobeNewswire Inc. • 06/05/2024 11:01:00 AM
- Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q • GlobeNewswire Inc. • 05/30/2024 11:44:00 AM
- Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease • GlobeNewswire Inc. • 05/16/2024 12:01:00 PM
- Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K • GlobeNewswire Inc. • 04/24/2024 08:51:06 PM
- Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL • GlobeNewswire Inc. • 03/28/2024 12:01:00 PM
FEATURED $SYNX - Could Silynxcom Be the Next 1000% Israeli Defense Tech Rocketship? (NYSE: SYNX) • Mar 26, 2025 12:15 PM
FEATURED PMGC Holdings Announces Share Repurchases from Existing Shareholders • Mar 26, 2025 12:00 AM
ConnectM Issues Stockholder Letter from CEO & Chairman • CNTM • Mar 26, 2025 12:14 PM
4Cable TV International, Inc. To Change Name to Opus Holdings, Inc. Set to Launch New Business Model with Potential Shareholder Dividends and a Fresh Leadership Team • CATV • Mar 25, 2025 8:30 AM
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform • AVAI • Mar 25, 2025 8:00 AM
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant • HLYK • Mar 24, 2025 8:00 AM